Showing results (101-110 of 467) with videos related to

Sort By:
Pageof 47
Current Pharmaceutical Biotechnology|August 10, 2021
Beta-glucans is a Potential Inhibitor of Ovarian Cancer: Based on Molecular and Biological AspectsFatemeh Sadoughi, Zatollah Asemi, Jamal Hallajzadeh, et al.
Journal of Cellular Physiology|June 27, 2019
Circular RNAs: A novel biomarker for cervical cancerShala Chaichian, Rana Shafabakhsh, Seyyed Mehdi Mirhashemi, et al.
IUBMB Life|December 25, 2019
Chitosan is a potential inhibitor of ovarian cancer: Molecular aspectsMaryam Chamani, Parisa Maleki Dana, Shahla Chaichian, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 26, 2015
Effects of beta-carotene fortified synbiotic food on metabolic control of patients with type 2 diabetes mellitus: A double-blind randomized cross-over controlled clinical trialZatollah Asemi, Sabihe-Alsadat Alizadeh, Khorshidi Ahmad, et al.
Biochimie|May 31, 2022
Molecular basis of melatonin protective effects in metastasis: A novel target of melatoninFatemeh Sadoughi, Parisa Maleki Dana, Mina Homayoonfal, et al.
Mini Reviews in Medicinal Chemistry|January 28, 2022
Resveratrol and Cervical Cancer: A New Therapeutic OptionRana Shafabakhsh, Russel J Reiter, Michael Aschner, et al.
Current Pharmaceutical Design|September 28, 2021
Nanocellulose-based Delivery Systems and Cervical Cancer: Review of the LiteratureFatemeh Sadoughi, Jamal Hallajzadeh, Zatollah Asemi, et al.
Journal of Ovarian Research|March 12, 2021
Molecular and biological functions of gingerol as a natural effective therapeutic drug for cervical cancerParinaz Zivarpour, Elhameh Nikkhah, Parisa Maleki Dana, et al.
Cancer Cell International|July 26, 2019
Resveratrol is a promising agent for colorectal cancer prevention and treatment: focus on molecular mechanismsMohadese Honari, Rana Shafabakhsh, Russel J Reiter, et al.
Pageof 47